Showing posts with label increased risk. Show all posts
Showing posts with label increased risk. Show all posts

Monday, December 2, 2019

Early Menopause,Smoking Increase Risk of Heart Failure

A new study by Swedish researchers has found that women who experience an early menopause are at increased risk for heart failure. In addition, smoking increases that risk. The study was published online on May 12 in the journal Menopause.

Early-Menopause-Increases-Heart-Failure-Risk-Especially-For-Smokers


The investigators conducted a study to determine whether younger age at natural menopause carries a risk of heart failure. They also evaluated whether smoking modified that risk. They used data from the Swedish Mammography Cohort, which comprised 22,256 postmenopausal women. Age of natural menopause was noted and the women were followed from 1997 through 2011. The women’s first episode of heart failure was determined through the Swedish National Patient Register and the Cause of Death Register. The data was subjected to statistical analysis to determine the risk of heart failure.

The investigators found that during an average follow-up of 13 years, 2,532 first events of heart failure hospitalizations and deaths occurred. The average age at menopause was 51 years. Early natural menopause (40-45 years), compared to menopause at ages 50 to 54 years, was significantly associated with heart failure (1.40-fold increased risk). When the data was analyzed in regard to smoking status, a similar increased risk was found among women who did not experience an early menopause and smoked. In addition, women who smoked were more likely to experience an early menopause. The investigators found a significant interaction between age at natural menopause and smoking.

The authors concluded that their study found that women who experience an early natural menopause are at increased risk for developing heart failure. In addition, smoking can modify the association by increasing the risk even among women who enter menopause from ages 46 to 49 years.

This study is in agreement with a study published September 18, 2011 in the journal Menopause. Study author Dr. Volodymyr Dvornyk, from the University of Hong Kong, noted that women “should be aware of this effect and possible health consequences” of smoking, in addition to its other known risks. He and his research team conducted a meta-analysis, which pooled data from six studies of approximately 6,000 women in the U.S., Poland, Turkey, and Iran. It revealed that women who smoke may enter menopause about a year earlier than nonsmokers. On average, non-smokers reached the menopause between age 46 and 51, depending on the study population. In all but two of the studies, smokers were younger: between age 43 and 50. The researchers also reviewed five other studies that used a cut-off age of 50 or 51 to stratify women into “early” and “late” menopause groups. Among the more than 43,000 women in that analysis, smokers were 43% more likely than nonsmokers to have early menopause. They wrote, “Our results give further evidence that smoking is significantly associated with earlier [age at menopause] and provide yet another justification for women to avoid this habit.”

Early Menopause Could Raise Risk of Heart Disease

One in five women in Los Angeles smoke, according to the Los Angeles County Department of Public Health. These women are at significantly increased for cardiovascular disease, chronic obstructive pulmonary disease (COPD), lung cancer, and other cancers.

Source: http://m.edtreatmentindia.com/

Monday, November 4, 2019

Some Women May be at Increased Breast Cancer Risk After Estrogen Withdrawal


According to a two-year study by researchers at UCLA Jonsson Comprehensive Cancer Center, some women with an inherited mutation, known as the KRAS-variant, may be at increased risk to breast cancer after abrupt estrogen withdrawal. The findings were published on May 11 in the journal Cell Cycle.

If You're Experiencing These Signs You May Have High Estrogen

Check this Article: Penile Implant Surgery in India

The study was led by Joanne Weidhaas, MD, PhD, a UCLA Jonsson Comprehensive Cancer Center member and director of translational research at the David Geffen School of Medicine. Her team analyzed data from a group of more than 1,700 breast cancer patients who all furnished DNA samples to be tested for the inherited KRAS-variant. The study also included a group of women with the KRAS-variant who did not have cancer, as well as biological models to scientifically confirm the clinical findings.

The investigators found that acute estrogen withdrawal, such as ovary removal without estrogen replacement, discontinuation of Hormone Replacement Therapy (HRT) as experienced after ovary removal, or with hormone replacement therapy discontinuation, and/or a low estrogen state in women with the KRAS-variant produced an increased breast cancer risk. Acute estrogen withdrawal also triggered breast cancer formation in the KRAS-variant biological models that were used in the study. In addition, the researchers found that up to 455 of breast cancer patients with the KRAS-variant went on to develop a second independent breast cancer; thus, marking a 12-fold increased risk over breast cancer patients without the KRAS-variant.

Previous studies have reported that the KRAS-variant, which is present in 1 out of 17 individuals, or 6 % of the world's population, predicts an increased risk of various cancers, including breast cancer; furthermore, it is present in up to 20%of newly diagnosed cancer patients. I addition, a previous study showed that women with the KRAS-variant are significantly more likely to develop both breast and ovarian cancer.

Dr. Weidhaas explained, "Although we had evidence that the KRAS-variant was a stronger predictor of cancer risk for women than men, we did not previously have a scientific explanation for this observation. This study's findings, showing that estrogen withdrawal can influence cancer risk for women with the KRAS-variant, begins to provide some answers."

The findings of the study contrast with some past ones that suggested that women on combination hormone replacement therapy are more likely to develop breast cancer. However, they are in agreement with follow-up studies that found estrogen alone may actually protect women from breast cancer. Dr. Weidhaas said, "The KRAS-variant may be a genetic difference that could actually help identify women who could benefit from continuing estrogen, or at a minimum, at least tapering it appropriately. We hope that there are real opportunities to personalize risk reducing strategies for these women, through further defining the most protective estrogen management approaches, as well as by understanding the impact of different treatment alternatives at the time of a woman's first breast cancer diagnosis."

Estrogen Withdrawal Increase to Breast Cancer